ArticleMalaria journal2025
The pattern of gene amplification of members of the Plasmodium vivax erythrocyte binding-like proteins family across the Amazon rainforest.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
backgroundIn Plasmodium vivax malaria, the Duffy Binding Protein (DBP), a key erythrocyte binding-like (EBL) protein, enables invasion of DARC (Duffy Antigen/Receptor for Chemokines) positive reticulocytes. Another EBL member, the erythrocyte binding protein 2 (EBP2, also known as EBP/ DBP2), shares structural features with DBP, suggesting a role in erythrocyte invasion. P. vivax genomes may harbour multiple ebl gene copies, though their functional role is unclear. Considering DBP and EBP2 as key vaccine candidates, this study investigates copy number variation (CNV) in these two ebl genes across Amazonian populations. Furthermore, the relationship between CNV and host DARC genotypes was investigated, as DARC is the best-characterized host receptor associated with susceptibility or resistance to P. vivax.
methodsA total of 191 P. vivax isolates from three malaria-endemic sites of the Amazon region (eastern, western, and southwestern) were analysed. DARC polymorphisms associated with functional (FY*A, FY*B) and non-functional (FY*B
resultsAmplification of dbp and ebp2 genes varied across Amazon regions. In the western region, 25% of P. vivax isolates showed dbp gene amplification (up to 8 copies), compared to 2-9% in the southwestern and eastern regions (2-3 copies). Overall, ebp2 amplification was less frequent, detected in 15% of P. vivax isolates from the western and in 1-4% from other regions. In the study areas, all individuals were DARC positives, and no association was observed between gene CNVs and DARC genotypes.
conclusionsThis study identifies dbp and ebp2 gene amplifications in P. vivax isolates from the Amazon rainforest, with regional CNV variation but no association with any DARC-positive genotype. These findings support further investigation into gene amplifications to elucidate their biological and immunological significance in DARC-positive populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.